ArticleOncotarget2024

Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma.

Jinhua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.